C71T
CANCELLED SECTION 71
07/03/2026
Back to search
Official data from USPTO
CAELUS HEALTH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
07/28/2026
Trademark type
Combined
Nice classes
5, 10
Filing date
09/22/2016
Registration date
12/17/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/03/2026
Last transaction
07/28/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
5
Owner type
26
Owner location
NL
Examiner
CORWIN, KEVIN SCOTT
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Caelus Pharmaceuticals B.V.
Representatives
R. Glenn Schroeder Schroeder Law PC
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for treating cardiometabolic disorders; dietetic foodstuffs adapted for medical use and dietetic substancesdietetic foods adapted for medical use; food supplements for human beings; medical preparations and articles for the treatment of cardiometabolic disorders; pharmaceutical products and natural medicinesboth for the treatment of cardiometabolic disorders; pharmaceutical preparationsmedicinesfor the prevention of diabetes mellitusCrohn's disease and ulcerative colitis disease; pharmaceutical preparationsmedicines for the treatment of diabetes mellitusCrohn's diseaseulcerative colitis disease and metabolic syndrome being insulin resistance; dietetic nutritional food additives for medical purposes in the nature of natural food extracts derived from gut-microbiota and dietetic preparationsdietary supplements; dietary food preparationsdietetic nutritional food additives for medical purposes in the nature of natural food extracts derived from gut-microbiota and dietetic substances in the nature of dietary supplements for the prevention of diabetes mellitusCrohn's disease and ulcerative colitis disease; dietary food preparationsdietetic nutritional food additives for medical purposes in the nature of natural food extracts derived from gut-microbiota and dietetic substances in the nature of dietary supplements for the treatment of diabetes mellitusCrohn's diseaseulcerative colitis disease and metabolic syndrome being insulin resistance; preparationscultures of microorganisms for medical useincluding bacterial preparations
Class 10
Medical diagnostictesting and monitoring equipmentblood testing apparatus for measuring insulin levels and Advanced Glycation Endproducts; medical test kits for home monitoring of diabetes
Publications
History of USPTO decisions and trademark events.
45 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
12/17/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/30/2023
GPNX
NOTIFICATION PROCESSED BY IB
05/01/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/01/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/31/2020
FIMP
FINAL DISPOSITION PROCESSED
03/30/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/17/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
12/17/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/01/2019
PUBO
PUBLISHED FOR OPPOSITION
10/01/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/11/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/11/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/11/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/23/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/22/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/22/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/22/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/08/2019
GNFR
FINAL REFUSAL E-MAILED
07/08/2019
CNFR
FINAL REFUSAL WRITTEN
07/08/2019
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
12/14/2018
DOCK
ASSIGNED TO EXAMINER
12/12/2018
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
10/06/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/19/2018
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
09/19/2018
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
06/14/2018
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/15/2017
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/10/2017
GNSL
LETTER OF SUSPENSION E-MAILED
12/10/2017
CNSL
SUSPENSION LETTER WRITTEN
12/10/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/14/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/14/2017
ALIE
ASSIGNED TO LIE
11/03/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/24/2017
RFNT
REFUSAL PROCESSED BY IB
05/13/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/24/2017
RFRR
REFUSAL PROCESSED BY MPU
04/24/2017
MAFR
APPLICATION FILING RECEIPT MAILED
04/21/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/20/2017
CNRT
NON-FINAL ACTION WRITTEN
04/19/2017
DOCK
ASSIGNED TO EXAMINER
04/17/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/17/2017
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
04/14/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/13/2017
Continuous trademark protection
Get notified about every new filing that threatens CAELUS HEALTH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.